NIAID to Fund Biodefense Dx Development Projects | GenomeWeb

By a GenomeWeb staff reporter

NEW YORK (GenomeWeb News) – The National Institute of Allergy and Infectious Diseases will spend $9.3 million in Fiscal Year 2013 to fund research and development of new diagnostic and therapeutic countermeasures for use in biodefense efforts against dangerous pathogens and toxins.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

In Science this week: role for epigenetic in neuronal excitability, and more.

The new Office of Research Integrity director is grappling with complaints from her staff, according to ScienceInsider.

Italian researchers link SNPs in the PDSS2 gene to coffee consumption in a new paper.

A gene-editing ban has been interpreted to include mitochondrial transfer, Technology Review reports.